Molecular Therapy-Nucleic Acids

Papers
(The H4-Index of Molecular Therapy-Nucleic Acids is 44. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
MicroRNA-466 and microRNA-200 increase endothelial permeability in hyperglycemia by targeting Claudin-5153
All roads lead to cure: Diversity of oligonucleotides in DM1 therapy118
Inefficacy of anti-VEGF therapy reflected in VEGF-mediated photoreceptor degeneration86
Insights into the regulatory role of epigenetics in moyamoya disease: Current advances and future prospectives77
Endothelial derived, secreted long non-coding RNAs Gadlor1 and Gadlor2 aggravate cardiac remodeling75
Effective intravitreal gene delivery to retinal pigment epithelium with hyaluronic acid nanospheres74
Activating the Cpx response induces tolerance to antisense PNA delivered by an arginine-rich peptide in Escherichia coli74
Gene-repressing epigenetic reader EED unexpectedly enhances cyclinD1 gene activation71
Cas-CLOVER is a novel high-fidelity nuclease for safe and robust generation of TSCM-enriched allogeneic CAR-T cells70
LinQURE: A novel AAV gene silencing platform that supports multi-transcript targeting for complex disorders69
AAV-vectored base editor trans-splicing delivers dystrophin repair69
RETRACTED: H3K27 demethylase KDM6B aggravates ischemic brain injury through demethylation of IRF4 and Notch2-dependent SOX9 activation69
Retraction Notice to: Hypoxic tumor-derived exosomal circular RNA SETDB1 promotes invasive growth and EMT via the miR-7/Sp1 axis in lung adenocarcinoma68
HOXA5-miR-574-5p axis promotes adipogenesis and alleviates insulin resistance67
Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 165
Single-swap editing for the correction of common Duchenne muscular dystrophy mutations65
A bimolecular modification strategy for developing long-lasting bone anabolic aptamer65
Exosomal miR-590-3p derived from cancer-associated fibroblasts confers radioresistance in colorectal cancer65
Modulation of miR-29 influences myocardial compliance likely through coordinated regulation of calcium handling and extracellular matrix63
Implications of miR-148a-3p/p35/PTEN signaling in tau hyperphosphorylation and autoregulatory feedforward of Akt/CREB in Alzheimer’s disease63
Antisense oligonucleotide-mediated exon 27 skipping restores dysferlin function in dysferlinopathy patient-derived muscle cells62
Unlocking RNA mysteries: Predicting subcellular localizations with AI62
Emerging roles of circRNAs in the pathological process of myocardial infarction59
Forced enhancer-promoter rewiring to alter gene expression in animal models59
Mitochondrial double-stranded RNAs as a pivotal mediator in the pathogenesis of Sjӧgren’s syndrome58
Alleviation of ischemia-reperfusion induced renal injury by chemically modified SOD2 mRNA delivered via lipid nanoparticles57
Novel insights into the interaction between N6-methyladenosine modification and circular RNA56
Enhanced molecular dynamic simulation studies unravel long-range effects caused by sequence variations and partner binding in RNA aptamers56
Highly efficient A-to-G base editing by ABE8.17 in rabbits55
Single-cell transcriptome profiling implicates the psychological stress-induced disruption of spermatogenesis54
Efficient transfected liposomes co-loaded with pNrf2 and pirfenidone improves safe delivery for enhanced pulmonary fibrosis reversion52
Right on target: The next class of efficient, safe, and specific RNAi triggers51
Engineering B cells with customized therapeutic responses using a synthetic circuit51
tRF-1001: A potential therapeutic target for ocular neovascular diseases51
RNA therapeutics in targeting G protein-coupled receptors: Recent advances and challenges49
Structural variants and modifications of hammerhead ribozymes targeting influenza A virus conserved structural motifs49
CleanCap M6 inhibits decapping of exogenously delivered IVT mRNA48
DNA-PKcs inhibition improves sequential gene insertion of the full-length CFTR cDNA in airway stem cells48
Nucleic acid delivery for pathology treatment: RNA tissue delivery47
Redefining NSP12 activity in SARS-CoV-2 and its regulation by NSP8 and NSP747
Extracellular viral microRNAs as biomarkers of virus infection in human cells47
miR-6077 promotes cisplatin/pemetrexed resistance in lung adenocarcinoma via CDKN1A/cell cycle arrest and KEAP1/ferroptosis pathways46
miR-204 suppresses cancer stemness and enhances osimertinib sensitivity in non-small cell lung cancer by targeting CD4445
HnRNP-L-regulated circCSPP1/miR-520h/EGR1 axis modulates autophagy and promotes progression in prostate cancer44
Cancer immunomodulation using bispecific aptamers44
Joint masking and self-supervised strategies for inferring small molecule-miRNA associations44
Double-stranded RNA induction asa potential dynamic biomarkerfor DNA-demethylating agents44
Precise detection of CRISPR-Cas9 editing in hair cells in the treatment of autosomal dominant hearing loss44
Inhibition of microRNA-30a alleviates vascular remodeling in pulmonary arterial hypertension44
0.061568021774292